chr12-79292133-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The NM_005639.3(SYT1):c.474+3C>A variant causes a splice donor region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.363 in 1,609,632 control chromosomes in the GnomAD database, including 108,470 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.36 ( 9950 hom., cov: 32)
Exomes 𝑓: 0.36 ( 98520 hom. )
Consequence
SYT1
NM_005639.3 splice_donor_region, intron
NM_005639.3 splice_donor_region, intron
Scores
2
Splicing: ADA: 0.0005512
2
Clinical Significance
Conservation
PhyloP100: 0.466
Genes affected
SYT1 (HGNC:11509): (synaptotagmin 1) This gene encodes a member of the synaptotagmin protein family. The synaptotagmins are integral membrane proteins of synaptic vesicles that serve as calcium sensors in the process of vesicular trafficking and exocytosis. The encoded protein participates in triggering neurotransmitter release at the synapse in response to calcium binding. Mutations in this gene are associated with Baker-Gordon syndrome. [provided by RefSeq, Jan 2023]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 12-79292133-C-A is Benign according to our data. Variant chr12-79292133-C-A is described in ClinVar as [Benign]. Clinvar id is 1334917.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.568 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SYT1 | NM_005639.3 | c.474+3C>A | splice_donor_region_variant, intron_variant | ENST00000261205.9 | NP_005630.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SYT1 | ENST00000261205.9 | c.474+3C>A | splice_donor_region_variant, intron_variant | 1 | NM_005639.3 | ENSP00000261205 | P3 |
Frequencies
GnomAD3 genomes AF: 0.356 AC: 54112AN: 151922Hom.: 9922 Cov.: 32
GnomAD3 genomes
AF:
AC:
54112
AN:
151922
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.372 AC: 92764AN: 249124Hom.: 18238 AF XY: 0.381 AC XY: 51307AN XY: 134662
GnomAD3 exomes
AF:
AC:
92764
AN:
249124
Hom.:
AF XY:
AC XY:
51307
AN XY:
134662
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.363 AC: 529407AN: 1457590Hom.: 98520 Cov.: 34 AF XY: 0.367 AC XY: 266058AN XY: 725212
GnomAD4 exome
AF:
AC:
529407
AN:
1457590
Hom.:
Cov.:
34
AF XY:
AC XY:
266058
AN XY:
725212
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.356 AC: 54180AN: 152042Hom.: 9950 Cov.: 32 AF XY: 0.357 AC XY: 26548AN XY: 74306
GnomAD4 genome
AF:
AC:
54180
AN:
152042
Hom.:
Cov.:
32
AF XY:
AC XY:
26548
AN XY:
74306
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1850
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
SYT1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 21, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at